Advertisement Genomma Lab acquires Medicinas y Medicamentos Nacionales - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Genomma Lab acquires Medicinas y Medicamentos Nacionales

Genomma Lab Internacional, an over-the-counter pharmaceuticals and personal care products company, has purchased 100% of the shares of Medicinas y Medicamentos Nacionales, a Mexican company.

Through this new subsidiary, Genomma Lab will sell new product lines within the categories of analgesics, cold remedies, anti-fungal, anti-inflammatory, expectorants and multivitamins, among others.

Genomma Lab said that it will apply its strategy of manufacturing these new product lines through third parties, thereby maintaining the high-quality standards that are characteristic of the company.